Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies with a VLP B-cell vaccines platform and ongoing preclinical development programs based on the platform.

Contact Information

Cytos Biotechnology AG, Wagistrasse 25
Schlieren 8952
Switzerland

Overview

Total FundingEmployeesLast Funding DateStatus
$125,574,05051-1002012-03-21Ipo

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2005-03-11$18,574,341Post Ipo Equity
2000-07-26$32,000,000Series BAlta Partners, New Medical Technologies, Lombard Odier, Novartis, Global Life Science Ventures, Aventic Partners AG, HealthCap
2012-03-21$40,000,000Post Ipo EquityvenBio Partners, Abingworth, Aisling Capital, Amgen Ventures
2002-01-23$27,000,000Series C
1999-01-01$7,999,709Series ANovartis, Global Life Science Ventures